MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1921 to 1940 of 166,322 approvalsPage 97 of 8317

Ornidazole Injection

Approval Number: 国药准字H20253023
Registration: Jan 2, 2025

Ceftazidime and Avibactam Sodium for Injection

Approval Number: 国药准字H20253047
Registration: Jan 2, 2025

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20253007
Registration: Jan 2, 2025

Telmisartan Tablets

Approval Number: 国药准字H20253064
Registration: Jan 2, 2025

Sacubitril Valsartan Sodium Tablets

Approval Number: 国药准字H20253014
Registration: Jan 2, 2025

Phloroglucinol Injection

Approval Number: 国药准字H20253027
Registration: Jan 2, 2025

Citicoline Sodium Injection

Approval Number: 国药准字H20253057
Registration: Jan 2, 2025

Vildagliptin Tablets

Approval Number: 国药准字H20253048
Registration: Jan 2, 2025

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20253006
Registration: Jan 2, 2025

Benidipine Hydrochloride Tablets

Approval Number: 国药准字H20253019
Registration: Jan 2, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20253030
Registration: Jan 2, 2025

Telmisartan Tablets

Approval Number: 国药准字H20253063
Registration: Jan 2, 2025

Cytarabine for Injection

Approval Number: 国药准字H20253065
Registration: Jan 2, 2025

Ciprofloxacin Hydrochloride and Fluocinolone Acetonide Ear Drops

Approval Number: 国药准字HJ20250004
Registration: Jan 2, 2025
laboratorios salvat, s.a.

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20253028
Registration: Jan 2, 2025

Everolimus Tablets

Approval Number: 国药准字H20253001
Registration: Jan 2, 2025

Desloratadine Oral Solution

Approval Number: 国药准字H20253004
Registration: Jan 2, 2025

Levetiracetam Tablets

Approval Number: 国药准字H20253017
Registration: Jan 2, 2025

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number: 国药准字H20253026
Registration: Jan 2, 2025

Aprepitant Injection

Approval Number: 国药准字H20253052
Registration: Jan 2, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.